BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28859917)

  • 21. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
    Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F
    Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
    Wu M; Guo J; Guo L; Zuo Q
    Tumour Biol; 2016 Sep; 37(9):12525-12533. PubMed ID: 27344157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time.
    Rieser CJ; Zenati M; Hamad A; Al Abbas AI; Bahary N; Zureikat AH; Zeh HJ; Hogg ME
    Ann Surg Oncol; 2018 Nov; 25(12):3483-3491. PubMed ID: 29786131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
    Shirai Y; Shiba H; Haruki K; Horiuchi T; Saito N; Fujiwara Y; Sakamoto T; Uwagawa T; Yanaga K
    Anticancer Res; 2017 Feb; 37(2):787-793. PubMed ID: 28179331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer.
    Otowa Y; Nakamura T; Yamamoto M; Kanaji S; Matsuda Y; Matsuda T; Oshikiri T; Sumi Y; Suzuki S; Kakeji Y
    Dis Esophagus; 2017 Dec; 30(12):1-5. PubMed ID: 28881893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical predictive factors of long-term survival after curative resection of pancreatic cancer: a retrospective study.
    Nakano Y; Kitago M; Shinoda M; Abe Y; Yagi H; Hibi T; Takeuchi A; Aiura K; Itano O; Kitagawa Y
    Cancer Med; 2017 Oct; 6(10):2278-2286. PubMed ID: 28925039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study.
    Aziz MH; Sideras K; Aziz NA; Mauff K; Haen R; Roos D; Saida L; Suker M; van der Harst E; Mieog JS; Bonsing BA; Klaver Y; Koerkamp BG; van Eijck CH
    Ann Surg; 2019 Jul; 270(1):139-146. PubMed ID: 29334554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Significance of Plasma Fibrinogen/Serum Albumin Ratio in the Postoperative Outcome of Pancreatic Ductal Adenocarcinoma.
    Tomita K; Ochiai S; Gunji T; Hikita K; Kobayashi T; Sano T; Chiba N; Kawachi S
    Anticancer Res; 2020 Dec; 40(12):7017-7023. PubMed ID: 33288597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
    Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
    BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
    Gao N; Yang RN; Meng Z; Wang WH
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy.
    Koh YW; Lee HW
    Medicine (Baltimore); 2017 May; 96(19):e6848. PubMed ID: 28489774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection.
    Shirai Y; Shiba H; Sakamoto T; Horiuchi T; Haruki K; Fujiwara Y; Futagawa Y; Ohashi T; Yanaga K
    Surgery; 2015 Aug; 158(2):360-5. PubMed ID: 26032829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel postoperative inflammatory score predicts postoperative pancreatic fistula after pancreatic resection.
    Fujiwara Y; Misawa T; Shiba H; Shirai Y; Iwase R; Haruki K; Furukawa K; Futagawa Y; Yanaga K
    Anticancer Res; 2013 Nov; 33(11):5005-10. PubMed ID: 24222143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal adenocarcinoma.
    Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
    Updates Surg; 2021 Feb; 73(1):251-259. PubMed ID: 32410163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ultimate preoperative C-reactive protein-to-albumin ratio is a prognostic factor for survival after pancreatic cancer resection.
    van Wijk L; de Klein GW; Kanters MA; Patijn GA; Klaase JM
    Eur J Med Res; 2020 Oct; 25(1):46. PubMed ID: 33028394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
    Xu XL; Yu HQ; Hu W; Song Q; Mao WM
    PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer.
    Zhou T; Zhan J; Hong S; Hu Z; Fang W; Qin T; Ma Y; Yang Y; He X; Zhao Y; Huang Y; Zhao H; Zhang L
    Sci Rep; 2015 Jun; 5():10481. PubMed ID: 26084991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.